Increased abundance of monounsaturated lipids and of elongated fatty-acid chains in phosphatidylinositol and phosphatidylserine lipids are noticed in prostate tumors, and importantly, phospholipid composition is altered in patients with response to AR inhibition [236]. This evidence concerns the gene AR and prostate neoplasm.